ARQT — Arcutis Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Arcutis Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	387	410	272	228	221
Net Total Accounts Receivable
Net Total Receivables	0.362	8.46	25.8	73.1	146
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	403	437	330	336	411
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.3	4.6	3.9	2.99	5.51
Net Intangible Assets
Other Long Term Assets
Total Assets	408	449	341	349	433
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	33.3	37.8	46.7	81	130
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	110	240	253	191	243
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	298	210	88.7	158	189
Total Liabilities & Shareholders' Equity	408	449	341	349	433
Total Common Shares Outstanding